Yilmaz Tonguc Utku, Yazihan Nuray, Dalgic Aydın, Kaya Ezgi Ermis, Salman Bulent, Kocak Mehtap, Akcil Ethem
School of Medicine, Department of General Surgery, Kocaeli University, Kocaeli, Turkey.
Indian J Med Res. 2015 Jun;141(6):807-15. doi: 10.4103/0971-5916.160713.
BACKGROUND & OBJECTIVES: Erythropoietin (EPO) has cytoprotective and anti-apoptotic effects in pathological conditions, including hypoxia and ischaemia-reperfusion injury. One of the targets to protect against injury is ATP-dependent potassium (KATP ) channels. These channels could be involved in EPO induced ischaemic preconditoning like a protective effect. We evaluated the cell cytoprotective effects of EPO in relation to KATP channel activation in the renal tubular cell culture model under hypoxic/normoxic conditions.
Dose and time dependent effects of EPO, KATP channel blocker glibenclamide and KATP channel opener diazoxide on cellular proliferation were evaluated by colorimetric assay MTT [3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide] under normoxic and hypoxic conditions in human renal proximal tubular cell line (CRL-2830). Evaluation of the dose and time dependent effects of EPO, glibenclamide and diazoxide on apoptosis was done by caspase-3 activity levels. Hypoxia inducible factor-1 alpha (HIF-1 α) mRNA levels were measured by semi-quantative reverse transcription polymerase chain reaction (RT)-PCR. Kir 6.1 protein expresion was evalutaed by Western blot.
Glibenclamide treatment decreased the number of living cells in a time and dose dependent manner, whereas EPO and diazoxide treatments increased. Glibenclamide (100 μM) treatment significantly blocked the anti-apoptotic effects of EPO (10 IU/ml) under both normoxic and hypoxic conditions. EPO (10 IU/ml) and diazoxide (100 μM) treatments significantly increased (p <0.01) whereas glibenclamide decreased ( p<0.05) HIF-1 α mRNA expression. Glibenclamide significantly ( p<0.01) decreased EPO induced HIF-1 α mRNA expression when compared with the EPO alone group.
INTERPRETATION & CONCLUSIONS: Our results showed that the cell proliferative, cytoprotective and anti-apoptotic effects of EPO were associated with KATP channels in the renal tubular cell culture model under hypoxic/normal conditions.
促红细胞生成素(EPO)在包括缺氧和缺血再灌注损伤在内的病理状态下具有细胞保护和抗凋亡作用。其保护免受损伤的靶点之一是ATP依赖性钾(KATP)通道。这些通道可能参与EPO诱导的缺血预处理样保护作用。我们在缺氧/正常氧条件下的肾小管细胞培养模型中,评估了EPO与KATP通道激活相关的细胞保护作用。
在人肾近端小管细胞系(CRL - 2830)中,通过比色法MTT[3 -(4,5 - 二甲基噻唑 - 2 - 基)- 2,5 - 二苯基四氮唑溴盐]在正常氧和缺氧条件下评估EPO、KATP通道阻滞剂格列本脲和KATP通道开放剂二氮嗪对细胞增殖的剂量和时间依赖性影响。通过半胱天冬酶 - 3活性水平评估EPO、格列本脲和二氮嗪对凋亡的剂量和时间依赖性影响。通过半定量逆转录聚合酶链反应(RT)-PCR测量缺氧诱导因子 - 1α(HIF - 1α)mRNA水平。通过蛋白质印迹法评估Kir 6.1蛋白表达。
格列本脲处理以时间和剂量依赖性方式减少活细胞数量,而EPO和二氮嗪处理则增加。在正常氧和缺氧条件下,格列本脲(100μM)处理均显著阻断了EPO(10 IU/ml)的抗凋亡作用。EPO(10 IU/ml)和二氮嗪(100μM)处理显著增加(p<0.01),而格列本脲则降低(p<0.05)HIF - 1αmRNA表达。与单独使用EPO组相比,格列本脲显著(p<0.01)降低了EPO诱导的HIF - 1αmRNA表达。
我们的结果表明,在缺氧/正常条件下的肾小管细胞培养模型中,EPO的细胞增殖、细胞保护和抗凋亡作用与KATP通道有关。